TrialInvestigational new drugs2014

Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial.

Sung-Bae Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.